Find Alintegimod manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 7hp349, 1378535-08-0, 7hp-349, Alintegimod [inn], Nx38vst3gu, Schembl6121788
Molecular Formula
C28H32N2O6S4
Molecular Weight
620.8  g/mol
InChI Key
PSBCCRKKPBQYJK-UHFFFAOYSA-N
FDA UNII
NX38VST3GU

Alintegimod
Alintegimod is an orally bioavailable, allosteric, small molecule activator of integrin cell adhesion receptors very late antigen-4 (VLA-4; integrin alpha4/beta1) and lymphocyte function-associated antigen-1 (LFA-1; integrin alphaL/beta2), with potential immunomodulatory and antineoplastic activities. Upon oral administration, alintegimod activates VLA-4 and LFA-1 expressed on the surface of leukocytes, thereby promoting the VLA-4- and LFA-1-mediated adhesion of leukocytes to counter-receptors vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). This may promote VLA-4/VCAM-1- and LFA-1/ICAM-1-mediated cell-cell adhesion between naive T-cells and antigen presenting cells (APCs) and enhance T-cell activation. The enhanced VCAM-1 and ICAM-1 binding by the activated integrins expressed on activated T-cells may also promote intratumoral T-cell accumulation and infiltration. This may lead to enhanced T-cell-mediated killing of tumor cells. Integrins VLA-4 and LFA-1 are cellular adhesion molecules (CAMs) that play key roles in antigen presentation and leukocyte migration.
1 2D Structure

Alintegimod

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[2-[2-[bis(thiophen-2-ylmethyl)carbamoyloxy]ethoxy]ethoxy]ethyl N,N-bis(thiophen-2-ylmethyl)carbamate
2.1.2 InChI
InChI=1S/C28H32N2O6S4/c31-27(29(19-23-5-1-15-37-23)20-24-6-2-16-38-24)35-13-11-33-9-10-34-12-14-36-28(32)30(21-25-7-3-17-39-25)22-26-8-4-18-40-26/h1-8,15-18H,9-14,19-22H2
2.1.3 InChI Key
PSBCCRKKPBQYJK-UHFFFAOYSA-N
2.2 Other Identifiers
2.2.1 UNII
NX38VST3GU
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 7hp349

2. 1378535-08-0

3. 7hp-349

4. Alintegimod [inn]

5. Nx38vst3gu

6. Schembl6121788

7. Chembl5314453

8. Glxc-26813

9. Da-70694

10. Ms-30785

11. Hy-152832

12. Cs-0641065

13. [ethane-1,2-diylbis(oxyethane-2,1-diyl)]bis{bis[(thiophen-2-yl)methyl]carbamate}

14. C,c'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)] Bis[n,n-bis(2-thienylmethyl)carbamate]

15. Carbamic Acid, N,n-bis(2-thienylmethyl)-, C,c'-[1,2-ethanediylbis(oxy-2,1-ethanediyl)] Ester

2.4 Create Date
2012-12-01
3 Chemical and Physical Properties
Molecular Weight 620.8 g/mol
Molecular Formula C28H32N2O6S4
XLogP34.6
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count10
Rotatable Bond Count19
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area191
Heavy Atom Count40
Formal Charge0
Complexity658
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Looking for 1378535-08-0 / Alintegimod API manufacturers, exporters & distributors?

Alintegimod manufacturers, exporters & distributors 1

43

PharmaCompass offers a list of Alintegimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Alintegimod manufacturer or Alintegimod supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Alintegimod manufacturer or Alintegimod supplier.

PharmaCompass also assists you with knowing the Alintegimod API Price utilized in the formulation of products. Alintegimod API Price is not always fixed or binding as the Alintegimod Price is obtained through a variety of data sources. The Alintegimod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Alintegimod

Synonyms

7hp349, 1378535-08-0, 7hp-349, Alintegimod [inn], Nx38vst3gu, Schembl6121788

Cas Number

1378535-08-0

Unique Ingredient Identifier (UNII)

NX38VST3GU

About Alintegimod

Alintegimod is an orally bioavailable, allosteric, small molecule activator of integrin cell adhesion receptors very late antigen-4 (VLA-4; integrin alpha4/beta1) and lymphocyte function-associated antigen-1 (LFA-1; integrin alphaL/beta2), with potential immunomodulatory and antineoplastic activities. Upon oral administration, alintegimod activates VLA-4 and LFA-1 expressed on the surface of leukocytes, thereby promoting the VLA-4- and LFA-1-mediated adhesion of leukocytes to counter-receptors vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule 1 (ICAM-1). This may promote VLA-4/VCAM-1- and LFA-1/ICAM-1-mediated cell-cell adhesion between naive T-cells and antigen presenting cells (APCs) and enhance T-cell activation. The enhanced VCAM-1 and ICAM-1 binding by the activated integrins expressed on activated T-cells may also promote intratumoral T-cell accumulation and infiltration. This may lead to enhanced T-cell-mediated killing of tumor cells. Integrins VLA-4 and LFA-1 are cellular adhesion molecules (CAMs) that play key roles in antigen presentation and leukocyte migration.

Alintegimod Manufacturers

A Alintegimod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Alintegimod, including repackagers and relabelers. The FDA regulates Alintegimod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Alintegimod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Alintegimod Suppliers

A Alintegimod supplier is an individual or a company that provides Alintegimod active pharmaceutical ingredient (API) or Alintegimod finished formulations upon request. The Alintegimod suppliers may include Alintegimod API manufacturers, exporters, distributors and traders.

Alintegimod GMP

Alintegimod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Alintegimod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Alintegimod GMP manufacturer or Alintegimod GMP API supplier for your needs.

Alintegimod CoA

A Alintegimod CoA (Certificate of Analysis) is a formal document that attests to Alintegimod's compliance with Alintegimod specifications and serves as a tool for batch-level quality control.

Alintegimod CoA mostly includes findings from lab analyses of a specific batch. For each Alintegimod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Alintegimod may be tested according to a variety of international standards, such as European Pharmacopoeia (Alintegimod EP), Alintegimod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Alintegimod USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty